REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,460 | -17.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $19,990 | +5.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,910 | +82117.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $23 | -99.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | +4.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -24.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $33,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -21.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $42,000 | +7.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | +14.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $34,000 | -24.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $45,000 | +60.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $28,000 | -24.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $37,000 | +15.6% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $32,000 | -22.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $41,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |